Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 1 year ago Source:  Heart Rhythm 2025
Heart Rhythm 2025 has released its program featuring five late-breaking clinical trials and science sessions which will take place from the 25th to 27thApril. The meeting is located in San Diego Convention Center, California. Access the full programme here.Late-Breaking Clinical Trials and Science: Clinical Trials Updates and RegistriesFriday 25th April, 11:45 – 12:45pm (PDT)A Multielectrode… View more
Author(s): Domenico G Della Rocca , Gian-Battista Chierchia Added: 1 year ago
Prof. Chierchia & Dr. Della Rocca share their perspectives on the PERFECT-PAF trial, which evaluates the clinical safety and economic value of FARAPULSETM PFA compared to cryoablation (CBA). In the interview, they highlight the study's design and key findings, along with its impact on clinical practice. View more
Added: 1 year ago Source:  ACC 2025
Watch our comprehensive coverage of ACC 2025's top trials here.The American College of Cardiology has announced the late-breaking trial and featured clinical research presentations for its 74th annual scientific sessions.ACC 2025 will be held from the 29th to 31st March at McCormick Place in Chicago.View the full programme here.Late-Breaking Clinical Trials I (Session 102)Saturday 29th March, 09… View more
Author(s): Luigi Di Biase Added: 4 months ago
Arrhythmia Academy Editor-in-Chief Dr Luigi Di Biase shares his expert perspective on the most practice-changing clinical trials emerging from the latest advances in atrial fibrillation management.In this highlights discussion, Dr Di Biase distills the key evidence that is reshaping clinical decision-making in AF ablation, anticoagulation strategies, and rhythm control approaches. Drawing from… View more
Author(s): Serge Boveda Added: 1 month ago
EHRA 2026 — Prof Serge Boveda (Clinic Pasteur, Toulouse, France) offers his expert perspective on the late-breaking trials from EHRA 2026 with the greatest potential to transform electrophysiology practice and redefine how clinicians approach arrhythmia management.In this incisive highlights video, Prof Boveda distils the most compelling evidence to emerge from Paris, translating landmark trial… View more
Author(s): Luigi Di Biase Added: 2 months ago
EHRA 2026 — In this highlights video from EHRA 2026, Prof Luigi Di Biase (Albert Einstein College of Medicine, US) offers expert analysis of the landmark late-breaking trials shaping the future of cardiac electrophysiology.Prof Di Biase distils the most clinically significant findings from the congress floor, exploring the data poised to influence arrhythmia management and electrophysiology… View more
Author(s): Vivek Reddy Added: 2 years ago
EHRA 24 - We interview Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, US) on a first-in-human clinical trial of a novel conformable "single-shot" pulsed field ablation (PFA) catheter for pulmonary vein isolation (PVI).This single arm trial aimed to assess the safety and efficacy of PVI using an 8Fr PFA catheter (SpherePVI, Affera Inc) in 30 patients across three centers.Interview… View more
Added: 1 year ago Source:  ESC Congress
The European Society of Cardiology has revealed 12 Hot-Line trial sessions to be presented at the end of August.ESC Congress 2024 will be held from the 30thAugust to the 2nd September at the ExCel Center in London. View the full programme here.Don't miss our video collection covering late-breaking data from ESC Congress 2024, including a preview of the most anticipated trials in View from the… View more
Author(s): Atul Verma Added: 7 months ago
AHA Scientific Sessions 2025 - Dr Atul Verma (McGill University Health Centre, Montreal, CA) joins us to share outcomes from OCEAN (NCT02168829). The prospective, open-label, randomised trial aimed to investigate ongoing oral anticoagulation with rivaroxaban 15 mg daily compared to antiplatelet therapy in patients with clinical stroke risk factors at least one year post-successful catheter… View more